Company AVE Science&Technology CO.,LTD

Equities

688067

CNE100005188

Medical Equipment, Supplies & Distribution

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sales per Business

Sales per region

Sector Diagnostic & Testing Substances

End-of-day quote Shanghai S.E. Other stock markets 06:00:00 2024-05-27 pm EDT			5-day change	1st Jan Change
15.88 ^CNY	-2.16%		-5.36%	-33.31%

Apr. 26	AVE Science&Technology CO.,LTD Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Feb. 27	AVE Science&Technology CO.,LTD Reports Earnings Results for the Full Year Ended December 31, 2023	CI

AVE Science & Technology Co Ltd is a China-based company principally engaged in the research and development, production, sales and service of medical clinical laboratory analysis instruments and supporting in vitro diagnostic reagents and medical consumables. The Companyâs main products include urine formed component analyzer, urine dry chemistry analyzer, urine full item automatic analyzer, automatic stool analyzer, automatic body fluid analyzer, reproductive tract secretion analyzer, and special supporting in vitro diagnostic reagents and medical consumables and other products. The Company's products are mainly used in inspection departments of various medical and health institutions. The Company distributes its products both in the domestic market and to overseas markets.

Number of employees: 492

CNY in Million	2022	Weight	2023	Weight	Delta
Reagent 55.2 %	106	53.8 %	111	55.2 %	+4.39%
Instrument 27.0 %	59	30.1 %	54	27.0 %	-8.59%
Consumable 16.1 %	27	13.9 %	32	16.1 %	+17.74%
Others 1.7 %	4	2.2 %	3	1.7 %	-20.62%

CNY in Million	2022	Weight	2023	Weight	Delta
China 94.5 %	179	93.2 %	186	94.5 %	+3.67%
Overseas 5.5 %	13	6.8 %	11	5.5 %	-16.48%

Managers	Title	Age	Since
Jian Wen Ding CEO	Chief Executive Officer	67	94-02-28
Kun Xiang Long DFI	Director of Finance/CFO	50	12-01-31
Xiao Dong Wang CHM	Chairman	58	00-11-30
Jun Lang BRD	Director/Board Member	43	16-02-29
Xiao Xia Duan BRD	Director/Board Member	44	07-04-30
Chang Qing Lin BRD	Director/Board Member	52	10-01-31
Feng Liang Zhou BRD	Director/Board Member	59	98-05-31
Teng Fei Zeng IRC	Investor Relations Contact	39	19-08-25

Members of the board	Title	Age	Since
Jian Wen Ding CEO	Chief Executive Officer	67	94-02-28
Feng Liang Zhou BRD	Director/Board Member	59	98-05-31
Chang Qing Lin BRD	Director/Board Member	52	10-01-31
Xiang Wang BRD	Director/Board Member	42	18-03-14
Qiu Lin Yang BRD	Director/Board Member	59	20-04-02
Xing Hu BRD	Director/Board Member	45	20-02-25
Xiao Dong Wang CHM	Chairman	58	00-11-30
Xiao Xia Duan BRD	Director/Board Member	44	07-04-30
Xian You Wang BRD	Director/Board Member	67	21-10-14
Jun Lang BRD	Director/Board Member	43	16-02-29

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	68,000,000	25,845,365 ( 38.01 %)	0	38.01 %

Name	Equities	%	Valuation
Gfund Management Co., Ltd. 4.653 %	643,959	4.653 %	1 M ¥
Broad Fund Management Co. Ltd. 3.317 %	459,023	3.317 %	1 M ¥
China Asset Management Co., Ltd. 3.133 %	433,675	3.133 %	997 127 ¥
Da Cheng Fund Management Co., Ltd. 2.814 %	389,440	2.814 %	895 420 ¥
Goldstate Capital Fund Management Co., Ltd. 1.915 %	265,069	1.915 %	609 460 ¥
Lion Fund Management Co., Ltd. 0.2623 %	36,300	0.2623 %	83 463 ¥
Zhong Ou Asset Management Co., Ltd 0.2283 %	31,600	0.2283 %	72 656 ¥
Shanghai Guotai Junan Securities Assets Management Co., Ltd. 0.1958 %	27,103	0.1958 %	62 317 ¥
Bank of China Investment Management Co., Ltd. 0.1698 %	23,499	0.1698 %	54 030 ¥
Sealand Securities Co., Ltd. (Investment Management) 0.0917 %	12,689	0.0917 %	29 175 ¥

AVE Science & Technology Co., Ltd.

Aiwei Medical Technology Park 26 Fuling Road, Xueshi Street

410208, Changsha

http://www.c-ave.com

address AVE Science&Technology CO.,LTD(688067)

Healthcare

Healthcare Services

Healthcare Equipment & Supplies

Medical Equipment, Supplies & Distribution

Diagnostic & Testing Substances

	1st Jan change	Capi.
AVE SCIENCE&TECHNOLOGY CO.,LTD	-33.31%	152M
BIOMÉRIEUX	-6.41%	12.2B
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.	-4.07%	8.22B
DIASORIN S.P.A.	+5.77%	5.72B
LANTHEUS HOLDINGS, INC.	+27.65%	5.42B
10X GENOMICS, INC.	-59.77%	2.7B
ANDON HEALTH CO., LTD.	+8.04%	2.63B
VITROLIFE AB	-6.47%	2.38B
MYRIAD GENETICS, INC.	+22.57%	2.1B
GUANGZHOU WONDFO BIOTECH CO.,LTD	-8.15%	1.81B

Diagnostic & Testing Substances